IDH1 Mutation Impacts DNA Repair Through ALKBH2 Rendering Glioblastoma Cells Sensitive to Artesunate. [PDF]
Switzeny O +3 more
europepmc +1 more source
Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
Jinquan Cai +12 more
openalex +2 more sources
Novel small-molecule therapies for myelodysplastic syndromes with IPSS-R ⩾3.5 in patients aged 60 or older: current landscape and challenges. [PDF]
Hou K, Dong X, Niu W.
europepmc +1 more source
Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R/R AML [Podcast]. [PDF]
Zeidan AM, Wang E.
europepmc +1 more source
Isocitrate dehydrogenase-mutant astrocytoma in persons aged 55 years and older: Survival differences versus the young. [PDF]
Siddiq Z +3 more
europepmc +1 more source
Factors affecting response and resistance to venetoclax in acute myeloid leukemia. [PDF]
Diamantidis MD.
europepmc +1 more source
Frontline treatment of IDH1-mutated myelodysplastic syndrome with ivosidenib: clinical cases and therapeutic insights. [PDF]
Antonios B, Dutton N, Fazal S.
europepmc +1 more source
Panoramic spatial enhanced resolution proteomics (PSERP) reveals tumor architecture and heterogeneity in gliomas. [PDF]
Xu Z +15 more
europepmc +1 more source
TCA cycle-derived oncometabolites in cancer and the immune microenvironment. [PDF]
Sarkar S, Chang CI, Jean J, Wu MJ.
europepmc +1 more source
Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML. [PDF]
Magee GH, Grunwald MR.
europepmc +1 more source

